Zacks: Analysts Anticipate Universal Health Services, Inc. (NYSE:UHS) Will Post Quarterly Sales of $2.76 Billion

Equities analysts forecast that Universal Health Services, Inc. (NYSE:UHS) will report $2.76 billion in sales for the current quarter, Zacks Investment Research reports. Six analysts have provided estimates for Universal Health Services’ earnings, with the highest sales estimate coming in at $2.79 billion and the lowest estimate coming in at $2.72 billion. Universal Health Services posted sales of $2.65 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 4.2%. The company is scheduled to issue its next earnings results on Thursday, October 24th.

According to Zacks, analysts expect that Universal Health Services will report full-year sales of $11.29 billion for the current year, with estimates ranging from $11.25 billion to $11.37 billion. For the next fiscal year, analysts anticipate that the company will report sales of $11.78 billion, with estimates ranging from $11.57 billion to $11.98 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that that provide coverage for Universal Health Services.

Universal Health Services (NYSE:UHS) last released its quarterly earnings data on Thursday, July 25th. The health services provider reported $2.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.49 by $0.27. The business had revenue of $2.86 billion during the quarter, compared to analysts’ expectations of $2.81 billion. Universal Health Services had a return on equity of 16.41% and a net margin of 7.25%. The business’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.47 EPS.

Several research firms have recently issued reports on UHS. Credit Suisse Group upped their price objective on Universal Health Services from $150.00 to $170.00 and gave the stock an “outperform” rating in a research report on Monday, July 29th. Barclays set a $145.00 price objective on Universal Health Services and gave the stock a “hold” rating in a research report on Friday, July 26th. UBS Group reissued a “buy” rating and issued a $151.00 target price on shares of Universal Health Services in a research report on Friday, June 7th. Royal Bank of Canada upped their target price on Universal Health Services to $165.00 and gave the company an “outperform” rating in a research report on Tuesday, July 30th. Finally, Bank of America upped their target price on Universal Health Services from $158.00 to $165.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company’s stock. Universal Health Services has a consensus rating of “Hold” and an average target price of $149.38.

In related news, EVP Marvin G. Pember sold 16,693 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $149.54, for a total value of $2,496,271.22. Following the completion of the transaction, the executive vice president now directly owns 83,379 shares of the company’s stock, valued at approximately $12,468,495.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert H. Hotz sold 7,309 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $148.01, for a total value of $1,081,805.09. Following the completion of the transaction, the director now directly owns 67,715 shares of the company’s stock, valued at $10,022,497.15. The disclosure for this sale can be found here. Corporate insiders own 12.60% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UHS. Pearl River Capital LLC purchased a new position in Universal Health Services in the 2nd quarter valued at approximately $35,000. Ellis Investment Partners LLC purchased a new position in Universal Health Services during the first quarter worth $40,000. Valeo Financial Advisors LLC purchased a new position in Universal Health Services during the second quarter worth $47,000. CSat Investment Advisory L.P. increased its position in Universal Health Services by 74.0% during the second quarter. CSat Investment Advisory L.P. now owns 362 shares of the health services provider’s stock worth $47,000 after buying an additional 154 shares in the last quarter. Finally, Financial Gravity Wealth Inc. purchased a new position in Universal Health Services during the first quarter worth $49,000. 86.45% of the stock is owned by hedge funds and other institutional investors.

Shares of NYSE:UHS traded up $1.98 on Thursday, hitting $147.35. 481,000 shares of the company’s stock were exchanged, compared to its average volume of 800,641. The firm’s 50-day moving average is $139.04 and its 200 day moving average is $131.69. The company has a market capitalization of $12.86 billion, a PE ratio of 15.46, a P/E/G ratio of 1.76 and a beta of 1.09. Universal Health Services has a 1-year low of $112.79 and a 1-year high of $157.79. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.17 and a current ratio of 1.27.

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 16th. Stockholders of record on Tuesday, September 3rd will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.54%. This is an increase from Universal Health Services’s previous quarterly dividend of $0.10. The ex-dividend date of this dividend is Friday, August 30th. Universal Health Services’s dividend payout ratio is 4.20%.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, outpatient facilities, and behavioral health care facilities. The company operates through Acute Care Hospital Services, Behavioral Health Care Services, and Other segments. Its hospital offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Further Reading: How is a buy-side analyst different from a sell-side analyst?

Get a free copy of the Zacks research report on Universal Health Services (UHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Universal Health Services (NYSE:UHS)

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.